These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1337677)

  • 1. Structure-function relationships in the interaction of amphipathic helical polypeptides with the gastric H/K ATPase.
    Cuppoletti J; Chernyak BV; Huang P; Malinowska DH
    Ann N Y Acad Sci; 1992 Nov; 671():443-5. PubMed ID: 1337677
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of polypeptides with the gastric (H+ + K+)ATPase: melittin, synthetic analogs, and a potential intracellular regulatory protein.
    Cuppoletti J; Malinowska DH
    Mol Cell Biochem; 1992 Sep; 114(1-2):57-63. PubMed ID: 1334229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory antibodies against gastric H,K-ATPase.
    de Pont JJ; van Uem TJ; Klaassen CH; Swarts HG
    Ann N Y Acad Sci; 1992 Nov; 671():446-8. PubMed ID: 1337678
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular and cellular regulation of the gastric proton pump.
    Asano S; Morii M; Takeguchi N
    Biol Pharm Bull; 2004 Jan; 27(1):1-12. PubMed ID: 14743830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sugar residues for recombinant gastric H+,K(+)-ATPase.
    Klaassen CH; Swarts HG; De Pont JJ
    Ann N Y Acad Sci; 1997 Nov; 834():101-3. PubMed ID: 9405790
    [No Abstract]   [Full Text] [Related]  

  • 6. Indomethacin inhibition of hog gastric H+/K(+)-ATPase arises from its effect on both the enzyme protein and the lipid bilayer.
    Du J; Li SG; Lin ZH
    J Biochem; 1994 Aug; 116(2):250-6. PubMed ID: 7822239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomeric structure of P-type ATPases observed by single molecule detection technique.
    Kaya S; Abe K; Taniguchi K; Yazawa M; Katoh T; Kikumoto M; Oiwa K; Hayashi Y
    Ann N Y Acad Sci; 2003 Apr; 986():278-80. PubMed ID: 12763821
    [No Abstract]   [Full Text] [Related]  

  • 8. Rutin exerts antiulcer effect by inhibiting the gastric proton pump.
    Dubey S; Ganeshpurkar A; Shrivastava A; Bansal D; Dubey N
    Indian J Pharmacol; 2013; 45(4):415-7. PubMed ID: 24014928
    [No Abstract]   [Full Text] [Related]  

  • 9. Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase.
    Tabuchi Y; Yashiro H; Hoshina S; Asano S; Takeguchi N
    Br J Pharmacol; 2001 Dec; 134(8):1655-62. PubMed ID: 11739241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of Tyr7, Tyr10, and Ser27 of alpha-chain in H+,K(+)-ATPase by intrinsic and extrinsic kinases.
    Togawa K; Kaya S; Mori M; Shimada A; Imagawa T; Taniguchi K; Mårdh S; Corbin J; Kikkawa U
    Ann N Y Acad Sci; 1997 Nov; 834():582-4. PubMed ID: 9405868
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition kinetics of the gastric H,K-ATPase by K-competitive inhibitor SCH28080 as a tool for investigating the luminal ion pathway.
    Vagin O; Munson K; Denevich S; Sachs G
    Ann N Y Acad Sci; 2003 Apr; 986():111-5. PubMed ID: 12763783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bone resorption by H+/K(+)-ATPase inhibitors.
    Sarges R; Gallagher A; Chambers TJ; Yeh LA
    J Med Chem; 1993 Sep; 36(19):2828-30. PubMed ID: 8410997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One way for the gastric proton pump.
    Nissen P
    EMBO J; 2009 Jun; 28(11):1535-6. PubMed ID: 19494845
    [No Abstract]   [Full Text] [Related]  

  • 15. SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain.
    Vagin O; Denevich S; Munson K; Sachs G
    Biochemistry; 2002 Oct; 41(42):12755-62. PubMed ID: 12379118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function.
    Pope AJ; Sachs G
    Biochem Soc Trans; 1992 Aug; 20(3):566-72. PubMed ID: 1330781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycationic peptides as nonhormonal regulators of chemosignal systems].
    Shpakov AO
    Zh Evol Biokhim Fiziol; 2009; 45(4):355-67. PubMed ID: 19764631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric H+,K+-ATPase by 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), an inhibitor of volume-regulated anion channel.
    Fujii T; Takahashi Y; Takeshima H; Saitoh C; Shimizu T; Takeguchi N; Sakai H
    Eur J Pharmacol; 2015 Oct; 765():34-41. PubMed ID: 26277321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the beta-subunit of the H(+)-K(+)-ATPase using an inhibitory monoclonal antibody.
    Chow DC; Forte JG
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1562-70. PubMed ID: 8279517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target molecular weight of the gastric (H+ + K+)-ATPase functional and structural molecular size.
    Saccomani G; Sachs G; Cuppoletti J; Jung CY
    J Biol Chem; 1981 Aug; 256(15):7727-9. PubMed ID: 6267022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.